Clinical and Experimental Dermatology

SEP 7, 2026 · JOURNAL ARTICLE

Real-world Drug Survival of Guselkumab in Patients With Psoriasis Stratified by Weight and Comorbidities: Retrospective, Observational Data From the British Association of Dermatologists Biologics and Immunomodulators Register

Clinical and Experimental Dermatology

Retrospective real-world registry analysis confirming sustained drug survival of guselkumab across weight, BMI, and comorbidity strata over 36 months, with consistent outcomes but limited by observational design and missing baseline data.

AUG 14, 2026 · JOURNAL ARTICLE

Body composition of hidradenitis suppurativa compared to psoriasis and healthy controls

Clinical and Experimental Dermatology

A well-designed cross-sectional study with adequate sample size and multivariable adjustment demonstrating clear differences in body composition between HS and comparators, but lacks longitudinal data or clinical outcome linkage to establish causation or clinical actionability.

AUG 14, 2026 · JOURNAL ARTICLE

Spontaneous regression of eruptive melanocytic naevi on cessation of a BRAF inhibitor

Clinical and Experimental Dermatology

A single case report documenting an observed phenomenon without experimental controls or comparison, providing descriptive evidence that warrants further investigation.